Related Experiment Video
Updated: May 30, 2026

Biological Compatibility Profile on Biomaterials for Bone Regeneration
Published on: November 16, 2018
Medical universities in Austria: impact of curriculum modernization on medical education
1Medical University Vienna, BEMAW, Vienna, Austria.
Abstract:
During the last decade medical education in Austria has seen more changes than in the whole of the previous century, with a complete overhaul of the structure of undergraduate curricula. Curricula now are organized in thematic, integrated modules, students have early patient encounters, the number of examinations has been drastically reduced, objective examinations have been introduced throughout the entire course as has skills training, and quality management is assured. As a consequence of the judgement of the European Court in 2005 against discrimination and in favour of equal treatment of EU citizens, free enrolment was abandoned and admission tests were introduced. In postgraduate training, licensing examinations are now obligatory. Crucial results from the point of view of students as well as with regard to the supply of manpower to the health care system are a sharp decrease in the formerly extremely long mean duration of study programmes and a sharp fall in drop-out rates. The now fully autonomous medical universities have the opportunity to intensify collaboration and to embark on a process of continuous renewal. Structural reform of undergraduate and postgraduate curricula will eventually ensure full equality of Austrian and other European medical qualifications.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Microbiota Modulation by Antibiotics
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Current Trends in Nursing I
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions